In 2001, the Marihuana Medical Access Regulations (MMAR) came into force, making medical cannabis production in Canada legal for the first time . Twelve years later, the Marihuana for Medical […] Read More >>
Achieving EU GMP (European Union Good Manufacturing Practices) compliance is crucial for exporting cannabis to Europe. Preparations for successfully achieving EU approval for export take a significant amount of effort […] Read More >>
dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in jurisdictions where cannabis is legal (whether for medical use or recreational use or both) on a federal level. We do not provide any consulting services whatsoever for cannabis-related business conducted in the United States of America, or in any of its States or Territories.
Stay abreast of regulatory updates, news, events, offers and more
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.